Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
oxaliplatin, Quantity: 50 mg
Accord Healthcare Pty Ltd
Oxaliplatin
Injection, concentrated
Excipient Ingredients: water for injections; lactose monohydrate
Intravenous Infusion
1 vial
(S4) Prescription Only Medicine
Oxaliplatin, in combination with fluorouracil and folinic acid, is indicated for: Adjuvant treatment of stage III (Duke's C) colon cancer after complete resection of the primary tumour; Treatment of advanced colorectal cancer.
Visual Identification: A clear, colourless solution in a clear glass vial. When examined under suitable conditions of visibility it should be practically free from visible particles.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Registered
2014-10-09